SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021821
Filing Date
2023-05-12
Accepted
2023-05-12 16:41:11
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elox-20230331.htm   iXBRL 10-Q 2059730
2 EX-10.1 elox-ex10_1.htm EX-10.1 104837
3 EX-31.1 elox-ex31_1.htm EX-31.1 17338
4 EX-31.2 elox-ex31_2.htm EX-31.2 18799
5 EX-32.1 elox-ex32_1.htm EX-32.1 9392
6 EX-32.2 elox-ex32_2.htm EX-32.2 9553
  Complete submission text file 0000950170-23-021821.txt   6591028

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elox-20230331_def.xml EX-101.DEF 110559
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elox-20230331_cal.xml EX-101.CAL 42668
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elox-20230331_lab.xml EX-101.LAB 351174
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elox-20230331_pre.xml EX-101.PRE 253327
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elox-20230331.xsd EX-101.SCH 43791
55 EXTRACTED XBRL INSTANCE DOCUMENT elox-20230331_htm.xml XML 1047994
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 23916545
SIC: 2836 Biological Products, (No Diagnostic Substances)